AstraZeneca Pharma India Ltd share price
You have to be logged in to add this to Watchlist.- ₹9,046.95(1.03%)February 11, 2026 15:29:15 PM IST
- NSE
- BSE
- Vol : 25.36 K (NSE + BSE)Last 20 day avg : 7.82 K
AstraZeneca Pharma India Ltd is trading 1.03% upper at Rs 9,046.95 as compared to its last closing price. AstraZeneca Pharma India Ltd has been trading in the price range of 9,219.25 & 8,974.05. The company posted a net profit of 54.22 Crores in its last quarter.Listed peers of AstraZeneca Pharma India Ltd include Divi's Laboratories (4.89%), Sun Pharmaceutical Industries (0.14%), Torrent Pharmaceuticals (-0.55%).The Mutual Fund holding in AstraZeneca Pharma India Ltd was at 5.43% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in AstraZeneca Pharma India Ltd was at 2.71% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 11, 2026, 04:23 PM UTC
- BetaLow volatility0.43Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.38Annual dividends as a percentage of the stock price.
- P/BHigher than historical values27.23The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values105.31Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,474.50 | 4.89 | 1,72,371.90 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,709.95 | 0.14 | 4,10,264.62 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,056.80 | -0.55 | 1,37,483.76 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Moderately Bearish | 1,349.40 | 0.54 | 1,09,000.72 | 22.95 | 3.87 | 0.87 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,266.10 | 0.83 | 1,05,545.73 | 18.63 | 3.14 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE203A01020
- BSE Code506820
- NSE Code
AstraZeneca Pharma India Ltd is trading at 9046.95 as on Wed Feb 11 2026 09:59:15. This is 1.03% upper as compared to its previous closing price of 8954.50.
The market capitalization of AstraZeneca Pharma India Ltd is 22643.93 Cr as on Wed Feb 11 2026 09:59:15.
The 52 wk high for AstraZeneca Pharma India Ltd is 10653.05 whereas the 52 wk low is 6501.60
AstraZeneca Pharma India Ltd can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: -
- Dividend Yield: %
- D/E ratio: -
AstraZeneca Pharma India Ltd reported a net profit of 115.74 Cr in 2025.
The Mutual Fund Shareholding was 5.43% at the end of 31 Dec 2025.